Women’s Protection in Telehealth Act

This bill amends Medicare rules to permanently exclude from the program any provider who prescribes, administers, dispenses, or furnishes abortion-inducing drugs via telehealth without meeting four specific requirements: being a physician, physically examining the patient, being present in the same room during drug administration, and scheduling an in-person follow-up within 14 days. It directly affects Medicare providers offering telehealth abortion services that don't comply with these in-person conditions. The law defines "abortion-inducing drug" broadly as any substance prescribed to terminate a pregnancy with knowledge it will likely cause fetal death. Providers failing to meet these conditions face permanent Medicare exclusion, with no exceptions for telehealth services.